Drugs / mesenchymal stromal cells
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT02846883 Comparator | Dec 2016 → Sep 2021 | abdominal aortic aneurysm | VA Office of Research and Development | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | mesenchymal stromal cells | “allogeneic (not cells of the participant but those of another human) mesenchymal stromal cells (MSCs)” NCT02846883 ↗ |
| Known as | MSCs | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02846883 ↗ |
| Modality | Cell therapy | “allogeneic (not cells of the participant but those of another human) mesenchymal stromal cells (MSCs)” NCT02846883 ↗ |
| Route | Intravenous | “Intravenous infusion of 1 million allogeneic MSCs/kg.” NCT02846883 ↗ |